Tag: liver cancer

Liver Cancer Monotherapy Indication for Nivolumab Withdrawn

The indication for nivolumab (Opdivo) as monotherapy for hepatocellular carcinoma (HCC) for patients previously treated with sorafenib has been voluntarily withdrawn by the manufacturer, Bristol-Myers...

Protein Expression May Predict HBV DNA Suppression

Stopping nucleoside analog therapy in patients with hepatitis B viral (HBV) infections results in sustained viral suppression in only a minority of patients, but a...

Tislelizumab Benefit in HCC Undimmed by Prior Therapies

With the novel immunotherapy tislelizumab, durable responses are achieved for patients with advanced hepatocellular carcinoma (HCC), regardless of the number of prior lines of therapy,...

Rapid Core Antigen HCV Tests Could Expand Accessibility

A proposed rapid diagnostic test for hepatitis C viral infections that combines an inexpensive but lower-sensitivity core-antigen test with lab RNA confirmation of negative tests...

Chemoimmunotherapy in Invasive Lobular Breast Cancer

The PD-L1 inhibitor atezolizumab (Tecentriq) combined with carboplatin has shown signs of clinical activity in women with metastatic invasive lobular breast cancer (ILC) according to...

FDA Panel Votes Against Two Cancer Indications but Backs 4 of 6

Federal advisers this week supported the efforts of pharmaceutical companies in 4 of 6 cases in which these firms are fighting to maintain cancer indications...

Treatment Paradigm for Chronic HBV in Flux

These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD,...

Why Is Liver Cancer More Lethal for Black Patients?

By Denise Mann HealthDay Reporter THURSDAY, Feb 26, 2021 (HealthDay News) — Black people with hepatitis C develop liver cancer sooner than people in...

Most Common Cancer Diagnosis Globally: Breast Surpasses Lung

Breast cancer now tops the list of the most commonly diagnosed cancers worldwide, surpassing lung cancer for the first time, according to the latest global...

Patients Cured of HCV Still at High Liver Cancer Risk

NEW YORK (Reuters Health) – The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection...

Thousands of Excess Cancers Among American Indians/Alaska Natives, Especially in Southern Plains

NEW YORK (Reuters Health) – Liver, stomach, kidney, lung, colorectal and female breast cancers have a higher incidence rate among American Indian/Alaska Native (AI/AN) populations...

Trio Awarded Nobel Prize in Medicine for Discovering Hep C Virus

The Nobel Prize in Physiology or Medicine was awarded to two Americans and a British-born scientist this morning for the discovery of the hepatitis C...

Hepatocellular Carcinoma Shows Risk Factor Shift

Rates of hepatocellular carcinoma (HCC) continue to rise in the United States, but unevenly so given how the incidence has become highest in the Hispanic...

Ruth Bader Ginsburg Dies from Pancreatic Cancer

Sept. 18, 2020 — Justice Ruth Bader Ginsburg, a trailblazing jurist and the second woman appointed to the U.S. Supreme Court, died Friday. She...

RBG’s Cancer Returns; She’s Still Working

July 17, 2020 — Supreme Court Justice Ruth Bader Ginsburg said Friday she is on a course of chemotherapy to treat a recurrence of...

‘Momentous’ Data for First-Line Combo in Liver Cancer

New clinical data are set to change the treatment landscape for advanced liver cancer. This space has been dominated for a more than a decade...

FDA Approves First Targeted Drug for Bile Duct Cancer

The US Food and Drug Administration (FDA) has granted accelerated approval of a new targeted therapy for use in some patients with cholangiocarcinoma, a rare cancer...